Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 6 July 2009, doi:10.1136/bmj.b2719
Cite this as: BMJ 2009;339:b2719
| The first 150 words of the full text of this article appear below. |
When will ovarian cancer stop being called the silent killer?1 If it were truly silent, general practitioners could hardly be blamed for missing it. It is far from silent: its noise is difficult to interpret.
Recent studies of newly diagnosed women show that symptoms are common and reported to general practitioners.2 3 Although the symptoms are generally non-specific, general practitioners can identify a significant proportion of women requiring investigation. In the GP records of a recent cohort from Devon, soon to be published in the BMJ, 196 of the 212 women with primary ovarian cancer had either a symptom recorded or a mass noted before diagnosis. Eighty eight were referred for investigation on the same day as the first symptom was recorded, with a further 36 within the next week. This leaves a minority of women who experience diagnostic delays in primary care and who would benefit from a lowering
William Hamilton, general practitioner and consultant senior lecturer1, Alison Round, general practitioner2, Debbie Sharp, general practitioner and professor1
1 University of Bristol, Bristol BS8 2AA, 2 Castle Place Practice, Tiverton, Devon EX16 6NP
w.hamilton@bristol.ac.uk